Johnson & Johnson (JNJ) Current Deferred Tax Assets (2009 - 2015)
Johnson & Johnson (JNJ) posted Current Deferred Tax Assets of $3.6 billion for Q3 2015, down 3.14% sequentially from $3.7 billion in Q2 2015, and down 5.77% YoY from $3.8 billion in Q3 2014.
Johnson & Johnson (JNJ) Current Deferred Tax Assets (2009 - 2015) Analysis & Trends
Johnson & Johnson (JNJ) has 7 years of Current Deferred Tax Assets data on file, last reported at $3.6 billion in Q3 2015.
- Quarterly Current Deferred Tax Assets fell 5.77% year-over-year to $3.6 billion in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $3.6 billion (down 5.77% YoY) and the FY2014 annual result came in at $3.6 billion, down 1.11% from the prior year.
- Current Deferred Tax Assets eased to $3.6 billion in Q3 2015 per JNJ's latest filing, from $3.7 billion in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $4.1 billion in Q2 2014, with the low at $2.2 billion in Q1 2011.
- Average Current Deferred Tax Assets over 5 years is $3.2 billion, with a median of $3.3 billion recorded in 2012.
- Year-over-year, Current Deferred Tax Assets slipped 20.37% in 2011 and jumped 35.17% in 2012.
- Johnson & Johnson's Current Deferred Tax Assets stood at $2.5 billion in 2011, then increased by 26.57% to $3.1 billion in 2012, then rose by 14.91% to $3.6 billion in 2013, then declined by 1.11% to $3.6 billion in 2014, then rose by 1.09% to $3.6 billion in 2015.
- Business Quant data shows JNJ's Current Deferred Tax Assets at $3.6 billion in Q3 2015, $3.7 billion in Q2 2015, and $3.5 billion in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2015 | 3.61 Bn |
| Sep 27, 2015 | 3.61 Bn |
| Jun 28, 2015 | 3.72 Bn |
| Jun 28, 2015 | 3.72 Bn |
| Mar 29, 2015 | 3.52 Bn |
| Mar 29, 2015 | 3.52 Bn |
| Dec 28, 2014 | 3.57 Bn |
| Dec 28, 2014 | 3.57 Bn |
| Sep 28, 2014 | 3.83 Bn |
| Sep 28, 2014 | 3.83 Bn |
| Jun 29, 2014 | 4.10 Bn |
| Jun 29, 2014 | 4.10 Bn |
| Mar 30, 2014 | 3.92 Bn |
| Mar 30, 2014 | 3.92 Bn |
| Dec 29, 2013 | 3.61 Bn |
| Dec 29, 2013 | 3.61 Bn |
| Sep 29, 2013 | 3.49 Bn |
| Sep 29, 2013 | 3.49 Bn |
| Jun 30, 2013 | 3.28 Bn |
| Jun 30, 2013 | 3.28 Bn |